GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,279.00
Bid: 1,283.00
Ask: 1,285.00
Change: -35.00 (-2.66%)
Spread: 2.00 (0.156%)
Open: 1,311.00
High: 1,314.00
Low: 1,266.00
Prev. Close: 1,314.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Aug 2016 10:45

RNS Number : 0533H
Indivior PLC
12 August 2016
 

INDIVIOR PLC (the "Company")

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation

 

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Ingo Elfering

b)

Position / status

Chief Information Officer

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

 

Name

Indivior PLC

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of US$0.10

Ticker: IZQVF

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

US$3.88

10,000

 

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

 

e)

Date of the transaction

11/08/2016

f)

Place of the transaction

OTC Market in the USA

 

 

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Ingo Elfering

b)

Position / status

Chief Information Officer

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

 

Name

Indivior PLC

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

American Depositary Receipt (ADR) (note: 1 ADR is equivalent to 5 Ordinary Shares of US$0.10)

ISIN: US45579E1055

b)

Nature of the transaction

Purchase of ADR's

c)

Price(s) and volume(s)

Price(s)

Volume(s)

US$19.79

2,270

 

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

 

e)

Date of the transaction

11/08/2016

f)

Place of the transaction

OTC Market in the USA

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUCCRUPQUBP
Date   Source Headline
1st Mar 20218:00 amRNSTotal Voting Rights
18th Feb 20217:00 amRNSFinal Results
4th Feb 20211:55 pmRNSNotice of Results
3rd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20218:00 amRNSTotal Voting Rights
29th Jan 20214:58 pmRNSHolding(s) in Company
25th Jan 20215:14 pmRNSIndivior Reaches Settlement with Reckitt Benckiser
25th Jan 20218:00 amRNSHolding(s) in Company
20th Jan 20217:00 amRNSHolding(s) in Company
15th Jan 20213:04 pmRNSHolding(s) in Company
15th Jan 20217:00 amRNSIndivior Provides Preliminary FY 2020 Results
11th Jan 20211:00 pmRNSDirectorate Change
4th Jan 202110:29 amRNSTotal Voting Rights
4th Dec 202012:30 pmRNSDirector/PDMR Shareholding
4th Dec 20209:21 amRNSHolding(s) in Company
2nd Dec 20205:13 pmRNSHolding(s) in Company
30th Nov 20207:00 amRNSFurther statement re claim filed by RB
27th Nov 202011:24 amRNSClaim filed by Reckitt Benckiser Group - Amendment
27th Nov 202010:44 amRNSClaim filed by Reckitt Benckiser Group plc
24th Nov 20209:30 amRNSHolding(s) in Company
20th Nov 202011:30 amRNSAppointment of Chief Financial Officer
19th Nov 20207:00 amRNSAppointment of Non-Executive Chair
13th Nov 20207:00 amRNSCourt Approves Agreement with Justice Department
10th Nov 20207:00 amRNSIndivior to Participate in Upcoming Conferences
9th Nov 20208:48 amRNSBlock listing Interim Review
6th Nov 20202:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20204:45 pmRNSHolding(s) in Company
29th Oct 202011:00 amRNS3rd Quarter Results
23rd Oct 20207:00 amRNSStatement re US Court Sentencing of Former CEO
15th Oct 20207:00 amRNSNotice of Results
6th Oct 20209:10 amRNSHolding(s) in Company
5th Oct 20202:41 pmRNSHolding(s) in Company
1st Oct 20209:11 amRNSTotal Voting Rights
24th Sep 20207:00 amRNSStrategic Alignment Actions Announced
4th Sep 20205:31 pmRNSDirectorate Change
1st Sep 20208:00 amRNSHolding(s) in Company
18th Aug 20204:09 pmRNSHolding(s) in Company
10th Aug 20209:15 amRNSHolding(s) in Company
5th Aug 20208:00 amRNSHolding(s) in Company
3rd Aug 20207:18 amRNSTotal Voting Rights
30th Jul 20207:12 amRNSHalf-year Report
27th Jul 20204:00 pmRNSBoard Committee Change
27th Jul 202011:21 amRNSAdditional Listing
24th Jul 20203:24 pmRNSAgreement with US Department of Justice
17th Jul 20202:31 pmRNSHolding(s) in Company
16th Jul 20201:00 pmRNSNotice of Results
8th Jul 20208:00 amRNSHolding(s) in Company
1st Jul 20207:00 amRNSStatement re US Gov’t Agreement with Former CEO
29th Jun 20207:00 amRNSAppointment of Chief Executive Officer
24th Jun 202012:35 pmRNS24-Month Outcomes of RECOVER Study Presented

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.